Description
Latin name
Fucidin
Release form
Cream for external use 2% homogeneous, from white to almost white.
Packaging
In an aluminum tube 15 g of cream. In the package 1 tube.
Pharmacological action
Bacteriostatic antibiotic. It belongs to the group of fusidines, antimicrobial compounds, the mechanism of action of which is associated with a violation of protein synthesis in the bacterial cell.
Gram-positive bacteria and gram-negative cocci are susceptible to fusidic acid, for example, Staphylococcus aureus, Staphylococcus epidemridis (including methicillin-resistant strains), Nocardia asteroides, Corynebacterium minutissimum, Streptococcus pyogenesr.
Not active against Escherichia coli, Salmonella spp., Proteus spp., as well as protozoa and mushrooms.
Indications
Skin infections caused by bacteria sensitive to fusidic acid.
Contraindications
Hypersensitivity to the components of the drug.
Use in pregnancy and lactation
Experimental studies have shown that Fucidin G does not have embryotoxic and teratogenic effects. With external use of Futsidin G, the secretion of both fusidic acid and hydrocortisone with breast milk is unlikely due to low systemic adsorption. Since the study of women during pregnancy and lactation was not carried out, during pregnancy the drug should not be used for a long time and in large quantities, with breastfeeding – the drug should not be applied to the mammary glands.
Composition
1 g cream for external use contain: fusidic acid hemihydrate -20.4 mg (in terms of anhydrous acid) – 20 mg.
Excipients: cetyl alcohol – 111 mg, glycerol 85% – 111 mg, liquid paraffin – 111 mg, white soft paraffin – 56 mg, polysorbate 60 – 56 mg, hydrochloric acid – qs to pH 5, potassium sorbate – 2.7 mg, butylhydroxyanisole – 40 mcg, water – approx. 531 mg.
Dosage and administration
Cream is applied externally.
In adults and children from birth to 18 years, a cream is applied to the affected areas of the skin with a thin layer 3-4 times / day.
When using gauze dressings, the frequency of application can be reduced to 1-2 times / day.
The duration of treatment depends on the form and severity of the disease and averages 7-14 days.
Side effects
Side effects are very rare and can be expected in about 5% of patients.
Determination of the frequency of adverse reactions: very often (> 1/10), often (> 1/100 and <1/10), infrequently (> 1/1000 and <1/100), rarely (> 1/10 000 and <1/1000), very rare ( Dermatological reactions: infrequently – rash (erythematous, maculopapular, pustular), skin irritation, including pain, burning sensation, tingling sensation on the skin, itching, dry skin contact dermatitis rarely – eczema, periorbital edema, erythema Allergic reactions: rare – urticaria, angioedema, eczema From the side of the organ of vision: rarely – conjunctival irritation The patient must inform the doctor about the occurrence of any of the side or the above effects. Expiration 3 years. Deystvuyuschee substances Fuzydovaya acid Terms and conditions by the recipe dosage form cream Leo Pharmaceutical, Denmark
